SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?

Rapid antidepressant effects associated with ketamine have shifted the landscape for the

PDF) Pharmacological treatment of generalized anxiety disorder

PDF) Neuroprogression in schizophrenia: Pathways underpinning

The Patient Experience of Recovery Following Anti-NMDA Receptor

NMDA receptor activation requires remodelling of intersubunit

PDF) Cannabinoids and Vanilloids in Schizophrenia

Frontiers Can N-Methyl-D-Aspartate Receptor Hypofunction in

The NMDA receptor antagonist ketamine impairs and delays context

PDF) Does mismatch negativity have utility for NMDA receptor drug

SciELO - Brazil - Does mismatch negativity have utility for NMDA

SciELO - Brazil - Does mismatch negativity have utility for NMDA

Plants October-2 2022 - Browse Articles

Teste 2nd by Second Digital - Issuu

NMDA receptor trafficking in synaptic plasticity and